Acupuncture Effect on the Rate of Maturation in Post Term Pregnancies.
NCT ID: NCT04744168
Last Updated: 2021-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
128 participants
INTERVENTIONAL
2021-03-09
2021-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). The first purpose of this randomized study is to determine if five points of acupuncture : 4GI, 6RP, 34VB, 36E, 3F could improve the bishop score for prolonged pregnancies and decrease the rate of maturation.
The protocol of our study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side.
The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
NCT04407871
Randomized Controlled Trial of Acupuncture for Dysmenorrhea
NCT01116453
Acupuncture on Cardiac and Autonomic Function in Human Heart Failure
NCT01804816
The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture
NCT00200733
Acupuncture and Chinese Herbal Medicine for Long COVID
NCT07285707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The protocol of study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side.
At each consultation, the midwife collects the bishop's score to compare the average of it between the two arms and evaluate the rate of maturation.
The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.
Finally, the average duration of induction labour will analyze, duration of labour and delivery route between the two arms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupuncture
In the experimental arm, pregnant women at term will benefit one or two acupuncture sessions with five points : 4GI, 6RP, 34VB,36E,3F. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.
Acupuncture
Puncture of 5 points 4GI, 6RP, 34VB, 36E, 3F
Placebo acupuncture
In the placebo arm, pregnant women will benefit one or two acupuncture sessions with one point which is located outside the acupuncture meridian.
The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.
Placebo Acupuncture
Puncture of point HM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Puncture of 5 points 4GI, 6RP, 34VB, 36E, 3F
Placebo Acupuncture
Puncture of point HM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cephalic foetal presentation,
* Healthy or unicicatricial uterus,
* Major patientes,
* Speaking french,
* Term of the pregnancy determinated with a dating ultrasound between 11 weeks and 13 weeks+ 6 days,
* Having signed the form of consent participation.
Exclusion Criteria
* Diseases discoveries at 41 weeks : pre eclampsia, moves of the baby decrease, low amniotic fluid,anomalies of the foetal heartbeat
* Circled pregnancy,
* Twins or more,
* Foetal death in utero, medical termination of pregnancy,
* Unstuck membranes,
* Minor patients
* Patients who benefited acupuncture during pregnancy ,
* Imprecise term of delivery,
* Podalic presentation
* Patients under supervision or curatorship,
* Patients without social security.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Sud Francilien
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDRCB 2020-A03023-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.